BMRN

BioMarin Pharmaceutical Inc.

Contracts

Total Value

Stock Metrics

6.5%

Short % Float

7.4d to cover · Moderate squeeze

1.0%

Inst % Float

10 holders · 2026-06-30

Blackrock Inc.

Top Holder

10.6% of float

192.2M sh

Public Float

10/100

Dilution Score

Low

24+ mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

10/100

LOW

Inst: 1.04% · Top: Blackrock Inc.

Biotech Analytics

Rare Disease

52.82

Squeeze risk: MODERATE

Insider Buying0

Publications100

Dilution Risk10

Clinical Trials100

Short Interest30